Flashcard Set
6 questions in this set
Clinical practice flashcards for PMHNP students covering psychiatric assessment, diagnosis, pharmacology, and treatment planning for week 2 board certification preparation. Click each question to reveal the answer, or use the interactive study mode above for full flip-card practice with tracking.
Q1
What is the first-line pharmacological treatment for generalized anxiety disorder (GAD)?
SSRIs and SNRIs are first-line. Buspirone is also first-line for GAD. Benzodiazepines may be used short-term but are not recommended for long-term management due to dependence risk.
Q2
What PHQ-9 score indicates severe depression?
A PHQ-9 score of 20-27 indicates severe depression. Scores: 5-9 mild, 10-14 moderate, 15-19 moderately severe, 20-27 severe.
Q3
What is the C-SSRS and when is it used?
The Columbia Suicide Severity Rating Scale (C-SSRS) is a standardized tool assessing suicidal ideation and behavior. It is used in any psychiatric assessment where suicidal risk is present.
Q4
What are the DSM-5 criteria for a major depressive episode?
Five or more symptoms for at least 2 weeks, including depressed mood or anhedonia, plus: weight/appetite changes, sleep disturbance, psychomotor changes, fatigue, worthlessness/guilt, poor concentration, suicidal ideation.
Q5
What is the black box warning for antidepressants in young adults?
Increased risk of suicidal thinking and behavior in children, adolescents, and young adults up to age 24 during initial treatment, particularly in the first few weeks.
Q6
What is akathisia and which medications commonly cause it?
Akathisia is a movement disorder characterized by inner restlessness and compulsion to move. It is most commonly caused by antipsychotics and some antiemetics (metoclopramide).
Study Mode
Ready to practice all 6 cards?
The interactive study mode lets you flip cards, mark confidence levels, and track which questions you've mastered.
Open Study Mode →